Skip to main content
Log in

Cardiac troponin T in pregnant women having intravenous tocolytic therapy

  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract.

We studied drug-induced cardiotoxic effects in 22 pregnant women having tocolysis with intravenous fenoterol and verapamil. Because CK-MB is released from the uterus and placenta, we used the determination of cardiac troponin T (cTnT) as it is one of the most sensitive and specific indicators of myocardial necrosis. Cardiac troponin T levels were within physiological range (0.08± 0.01 μg/l) in all healthy pregnant women tested between 32 and 36 weeks of gestation (control group). In the pregnant women having tocolysis cTnT levels started to increase slightly during the first day of treatment (0.10±0.03 μg/l) and were significantly higher (p<0.05) during the third day (0.35±0.14 μg/l) of tocolytic therapy. The cTnT levels in cord blood (0.13±0.03 μg/l) did not correspond with maternal cTnT concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: February 1998 / Accepted: 29 September 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adamcová, M., Kokštein, Z., Palička, V. et al. Cardiac troponin T in pregnant women having intravenous tocolytic therapy. Arch Gynecol Obstet 262, 121–126 (1999). https://doi.org/10.1007/s004040050239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004040050239

Navigation